排序方式: 共有28条查询结果,搜索用时 15 毫秒
1.
G. O. Balabanyan 《Theoretical and Mathematical Physics》1991,89(1):1106-1119
Moscow Institute of Electronic Engineering. Translated from Teoreticheskaya i Matematicheskaya Fizika, Vol. 89, No. 1, pp. 132–150, October, 1991. 相似文献
2.
3.
4.
G. O. Balabanyan 《Theoretical and Mathematical Physics》1991,89(3):1329-1342
Moscow Institute of Electronic Engineering. Translated from Teoreticheskaya i Matematicheskaya Fizika, Vol. 89, No. 3, pp. 446–464, December, 1991. 相似文献
5.
6.
7.
G.O. Balabanyan 《Physics letters. A》1976,56(4):241-243
A hyperbolic system of hydrodynamic equations, containing second time derivatives, cross spatial-time second derivatives and products of spatial and time derivatives of hydrodynamics variables is obtained. 相似文献
8.
Theoretical and Mathematical Physics - 相似文献
9.
Tatyana Kovshova Nadezhda Osipova Anna Alekseeva Julia Malinovskaya Alexey Belov Andrey Budko Galina Pavlova Olga Maksimenko Shakti Nagpal Svenja Braner Harshvardhan Modh Vadim Balabanyan Matthias G. Wacker Svetlana Gelperina 《Molecules (Basel, Switzerland)》2021,26(4)
Targeted delivery of doxorubicin still poses a challenge with regards to the quantities reaching the target site as well as the specificity of the uptake. In the present approach, two colloidal nanocarrier systems, NanoCore-6.4 and NanoCore-7.4, loaded with doxorubicin and characterized by different drug release behaviors were evaluated in vitro and in vivo. The nanoparticles utilize a specific surface design to modulate the lipid corona by attracting blood-borne apolipoproteins involved in the endogenous transport of chylomicrons across the blood–brain barrier. When applying this strategy, the fine balance between drug release and carrier accumulation is responsible for targeted delivery. Drug release experiments in an aqueous medium resulted in a difference in drug release of approximately 20%, while a 10% difference was found in human serum. This difference affected the partitioning of doxorubicin in human blood and was reflected by the outcome of the pharmacokinetic study in rats. For the fast-releasing formulation NanoCore-6.4, the AUC0→1h was significantly lower (2999.1 ng × h/mL) than the one of NanoCore-7.4 (3589.5 ng × h/mL). A compartmental analysis using the physiologically-based nanocarrier biopharmaceutics model indicated a significant difference in the release behavior and targeting capability. A fraction of approximately 7.310–7.615% of NanoCore-7.4 was available for drug targeting, while for NanoCore-6.4 only 5.740–6.057% of the injected doxorubicin was accumulated. Although the targeting capabilities indicate bioequivalent behavior, they provide evidence for the quality-by-design approach followed in formulation development. 相似文献
10.
We study the nature of the superfluid-insulator quantum phase transition in a one-dimensional system of lattice bosons with off-diagonal disorder in the limit of a large integer filling factor. Monte Carlo simulations of two strongly disordered models show that the universality class of the transition in question is the same as that of the superfluid-Mott-insulator transition in a pure system. This result can be explained by disorder self-averaging in the superfluid phase and the applicability of the standard quantum hydrodynamic action. We also formulate the necessary conditions which should be satisfied by the stong-randomness universality class, if one exists. 相似文献